Table of Contents
Can HCC be cured?
Most people who develop HCC have cirrhosis, which is a build-up of scar tissue due to years of liver damage. Since HCC usually grows slowly in its early stages, it can often be cured if discovered early enough.
What does HCC do to the liver?
Hepatocellular carcinoma (HCC), or liver cancer, occurs when a tumor grows on the liver. It is responsible for over 12,000 deaths per year in the United States, making it one of the most serious cancers in adults.
Can you get a liver transplant if you have HCC?
Liver transplantation for treatment of HCC is attractive because resection of the malignant tumor can be achieved while also replacing the cirrhotic liver that remains at risk for the development of new lesions.
How fast can HCC grow?
Question 5: how fast do tumors grow? The mean volume doubling time of small (,5 cm) HCCs ranges from 112 to 204 days; the interindividual variability of tumor growth is also very high, the individual doubling time ranging from 30 to 600 days (34–38).
How quickly does HCC grow?
The estimated time needed for a HCC to grow from 1 cm to 2 cm was 212 days in patients with HBV infection and 328 days in those with HCV infection.
How long can you live with Stage 4 HCC?
In one small study of people with metastatic hepatocellular carcinoma, those whose liver cancer had spread to their lymph nodes or distant organs had an average survival rate of 4 and 11 months, depending on the severity of their liver damage and whether they received treatment.
Is HCC a solid tumor?
The most common primary malignancy of the liver in adults is hepatocellular carcinoma (HCC, or hepatoma). It is currently the fifth most common solid tumor worldwide and the third leading cause of cancer-related death.
Is HCC slow growing?
HCC patients with AFP levels ≤ 10.0 ng/mL had slower average growth rates compared to patients with AFP levels of 11.0-191 ng/mL and > 191 ng/mL (11.1\%, 18.7\%, and 30.3\% respectively, P = 0.029).
How aggressive is HCC?
Hepatocellular carcinoma (HCC) is an aggressive malignancy, resulting as the third cause of death by cancer each year. The management of patients with HCC is complex, as both the tumour stage and any underlying liver disease must be considered conjointly.